DIMERIX EXPANDS PIPELINE WITH ACQUISITION OF PHASE 2 READY ASSET FOR ACUTE KIDNEY INJURY
✦ NabkaNews BriefAuto-summarized from multiple outlets · verify with the source
Dimerix has acquired a phase 2 ready asset for the treatment of acute kidney injury, expanding its pipeline. The acquisition is reported to be for a drug candidate, with one outlet specifying it as DMX-652, aimed at expanding the company's rare kidney disease pipeline. The move is seen as boosting Dimerix's drug pipeline.
Full coverage
1
citybiz·1d ago2
TradingView·2d ago3
marketscreener.com·1d ago4
The Australian·1d ago5
Kalkine·2d ago6
The Manila Times·1d ago7The Manila Times·1d ago8
The Malaysian Reserve·Jul 6